Where the trial will be conducted

Researchers in the United Kingdom (Southampton), Singapore and New Zealand (Auckland) from the EpiGen Global Research Consortium will conduct the NiPPeR trial.

Researchers are based in the UK at the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU), University of Southampton; in Singapore at the National University of Singapore (NUS)National University Health System (NUHS), and Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR); and in New Zealand at the Liggins Institute and Researchers at the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU), University of Southampton, the National University of Singapore (NUS), National University Health System (NUHS)and Singapore Institute for Clinical Sciences of theAgency for Science, Technology and Research (A*STAR), Technology and Research (A*STAR), as well as at the Liggins Institute, at the University of Auckland and a satellite site in South Auckland.

 



To find out more about the country sites visit their country pages at the links to the right.